Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  George, J. N.
space
  arrow  Raskob, G. E.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

REPLY

Guidelines for Idiopathic Thrombocytopenic Purpura

right arrow James N. George, MD, and Gary E. Raskob, MSc

1 October 1997 | Volume 127 Issue 7 | Page 573


IN RESPONSE:

Caldwell and colleagues emphasize the important clinical point that chronic liver disease must be carefully considered as a possible cause of unexplained thrombocytopenia. Because idiopathic thrombocytopenic purpura can be diagnosed only by excluding other causes of thrombocytopenia [1], exclusion of chronic liver disease is essential. This has been emphasized in more comprehensive reviews on the condition.

The initial goal of the practice guideline on idiopathic thrombocytopenic purpura developed by the American Society of Hematology [1] was to evaluate the strength of the evidence supporting the value of diagnostic procedures and treatments. Evidence is lacking; thus, recommendations were based on an explicit method of measuring opinion of the American Society of Hematology panel. On the basis of opinion, the panel recommended that tests for platelet-associated IgG (the test used in the study by Kajiwara and colleagues [2] cited by Caldwell and coworkers) is unnecessary and inappropriate in the evaluation of patients suspected of having idiopathic thrombocytopenic purpura, in whom the history, physical examination, and complete blood counts with examination of the blood smear do not suggest another cause for the thrombocytopenia [1]. In normal persons, as well as in patients with chronic liver disease or other disorders, platelet-associated IgG is a platelet {alpha}-granule protein acquired by pinocytosis of plasma [3]. High levels of platelet-associated IgG do not imply an immunologic pathogenesis [3]. Furthermore, the panel recommended that tests for antigen-specific antiplatelet antibodies are unnecessary but may be appropriate [1]. These tests may be more specific for antiplatelet antibodies, but they are not standardized, have a wide range of sensitivity and specificity among research laboratories [4], and do not discriminate idiopathic thrombocytopenic purpura from nonimmune thrombocytopenias, such as gestational thrombocytopenia [5].

Thus, the diagnosis of idiopathic thrombocytopenic purpura remains clinical. All other possible causes of thrombocytopenia, especially common and potentially subtle disorders such as chronic liver disease, must be excluded by a careful evaluation.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

University of Oklahoma Health Sciences Center; Oklahoma City, OK 73190


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996; 88:3-40.

2. Kajiwara E, Akagi K, Azuma K, Onoyama K, Fujishima M. Evidence for an immunological pathogenesis of thrombocytopenia in chronic liver disease. Am J Gastroenterol. 1995; 90:962-6.

3. George JN. Platelet immunoglobulin G: is significance for the evaluation of thrombocytopenia and for understanding the origin of {alpha}-granule proteins. Blood. 1990; 76:859-70.

4. Berchtold P, Muller D, Beardsley D, Fujisawa A, Kaplan C, Kekomaki R, et al. International study to compare antigen-specific methods used for the measurement of antiplatelet autoantibodies. Br J Haematol. 1997; 96:477-83.

5. Lescale KB, Eddleman KA, Cines DB, Samuels P, Lesser ML, McFarland JG, et al. Antiplatelet antibody testing in thrombocytopenic pregnant women. Am J Obstet Gynecol. 1996; 174:1014-8.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  George, J. N.
space
  arrow  Raskob, G. E.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online